H.C. Wainwright Affirms Buy Rating on Alto Neuroscience (ANRO), Sets $10 PT
On Tuesday, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Alto Neuroscience Inc. (NYSE:ANRO) and set a price target of $10.00.
Alto Neuroscience Inc. (ANRO)
Market is closed
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.22 | 2,931 | $38,747.82 | 39,851 | 2024-07-10 | Filing | |
| $13.15 | 1,388 | $18,252.20 | 36,920 | 2024-07-09 | Filing | |
| $12.53 | 10,681 | $133,832.93 | 35,532 | 2024-07-09 | Filing | |
| $16.56 | 4,550 | $75,348.00 | 26,866 | 2024-03-28 | Filing | |
| $15.80 | 1,600 | $25,280.00 | 22,316 | 2024-03-28 | Filing |
News See All
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 ...
Billionaire Hedge Funds
